This follows the completion of a capital reduction exercise, which involved the cancellation of RM520 million in issued share capital.
Pharmaniaga Bhd fell into PN17 status in February 2023, dragged by its RM552.3 million provision for 'slow-moving inventories' of Covid-19 vaccines. KUALA LUMPUR: Pharmaniaga Bhd has completed its Practice Note 17 regularisation plan following the completion of its capital reduction exercise through the cancellation of RM520 million in issued share capital.
“The capital reduction exercise, which involved the cancellation of RM520 million in issued share capital, was completed after confirmation was received today from the registrar of companies that all statutory requirements have been fulfilled. “Following the completion of this exercise, the issued share capital of the group is RM249.62 million, comprising 6.55 billion shares,” it said in a statement. Pharmaniaga fell into PN17 status in February 2023, dragged by its RM552.
Pharmaniaga Bhd PN17 Regularisation Plan
Malaysia Latest News, Malaysia Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
US-Malaysia tariff deal expected after Trump-Anwar phone call, says reportPETALING JAYA: Pharmaniaga Bhd has completed a rights issue and a regularisation plan, allowing the company to remain on track to exit its PN17 status by the first quarter of 2026.
Read more »
Trump eyes 'world tariff' of 15-20% for most countriesPETALING JAYA: Pharmaniaga Bhd has completed a rights issue and a regularisation plan, allowing the company to remain on track to exit its PN17 status by the first quarter of 2026.
Read more »
One million affordable homes to be built from 2026 to 2035, says PM AnwarPETALING JAYA: Pharmaniaga Bhd has completed a rights issue and a regularisation plan, allowing the company to remain on track to exit its PN17 status by the first quarter of 2026.
Read more »
Audience moved to tears during pantomime of FRU crash tragedyPETALING JAYA: Pharmaniaga Bhd has completed a rights issue and a regularisation plan, allowing the company to remain on track to exit its PN17 status by the first quarter of 2026.
Read more »
Malaysia-US tariff talks concluded, awaiting Trump’s official response, says ZafrulPETALING JAYA: Pharmaniaga Bhd has completed a rights issue and a regularisation plan, allowing the company to remain on track to exit its PN17 status by the first quarter of 2026.
Read more »
New framework soon to address healthcare staffing issues, says PM AnwarPETALING JAYA: Pharmaniaga Bhd has completed a rights issue and a regularisation plan, allowing the company to remain on track to exit its PN17 status by the first quarter of 2026.
Read more »